Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Said Alsidawi

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Mayo Clinic Proceedings. Digital Health|April 10, 2025
Assessment of Positive Cardiac Remodeling in Hypertrophic Obstructive Cardiomyopathy Using an Artificial Intelligence-Based Electrocardiographic Platform in Patients Treated With MavacamtenMustafa Suppah, Kaitlin Roehl, Kathryn Lew, et al.
Tomography (Ann Arbor, Mich.)|March 26, 2025
Utility of Cardiac CT for Cardiomyopathy PhenotypingRamzi Ibrahim, Mahmoud Abdelnabi, Girish Pathangey, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|February 17, 2025
Rethinking Risk in Hypertrophic Cardiomyopathy: Assessing the Role of Myocardial Fibrosis and Left Ventricular Hypertrophy in Sudden Cardiac DeathAmro Badr, Juan Farina, Reza Arsanjani, et al.
Methodist Debakey Cardiovascular Journal|September 9, 2024
Surgical Removal of a Migrated WATCHMAN DeviceAndrew G Saleeb, Juan M Farina, Asher Jenkins, et al.
Mayo Clinic Proceedings|February 3, 2024
Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic CardiomyopathyJohn R Giudicessi, Said Alsidawi, Jeffrey B Geske, et al.
Methodist Debakey Cardiovascular Journal|June 24, 2024
Rapidly Progressive Apical Hypertrophic Cardiomyopathy: Not Everything is What It SeemsAhmed K Mahmoud, Juan M Farina, Kamal Awad, et al.
American Heart Journal|September 6, 2024
The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profileSaid Alsidawi, Kaitlin M Roehl, Juan Maria Farina, et al.
JACC. Advances|May 27, 2026
Long-Term Impact of Frailty on Outcomes Following Alcohol Septal Ablation in Hypertrophic Obstructive CardiomyopathyHritvik Jain, Nandan Patel, Jyoti Jain, et al.
Diabetes, Obesity & Metabolism|January 6, 2026
Increasing cardiovascular mortality in young adults with diabetes mellitus as a contributing cause in the United StatesYong-Hao Yeo, Boon-Jian San, Ghee-Kheng Lim, et al.
Biomedicines|April 29, 2025
Temporal Patterns of Holter-Detected Arrhythmias in Hypertrophic Cardiomyopathy Patients Treated with MavacamtenAmro Badr, Kaitlin Roehl, Mustafa Suppah, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Mayo Clinic Proceedings. Digital Health|April 10, 2025
Assessment of Positive Cardiac Remodeling in Hypertrophic Obstructive Cardiomyopathy Using an Artificial Intelligence-Based Electrocardiographic Platform in Patients Treated With MavacamtenMustafa Suppah, Kaitlin Roehl, Kathryn Lew, et al.
Tomography (Ann Arbor, Mich.)|March 26, 2025
Utility of Cardiac CT for Cardiomyopathy PhenotypingRamzi Ibrahim, Mahmoud Abdelnabi, Girish Pathangey, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|February 17, 2025
Rethinking Risk in Hypertrophic Cardiomyopathy: Assessing the Role of Myocardial Fibrosis and Left Ventricular Hypertrophy in Sudden Cardiac DeathAmro Badr, Juan Farina, Reza Arsanjani, et al.
Methodist Debakey Cardiovascular Journal|September 9, 2024
Surgical Removal of a Migrated WATCHMAN DeviceAndrew G Saleeb, Juan M Farina, Asher Jenkins, et al.
Mayo Clinic Proceedings|February 3, 2024
Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic CardiomyopathyJohn R Giudicessi, Said Alsidawi, Jeffrey B Geske, et al.
Methodist Debakey Cardiovascular Journal|June 24, 2024
Rapidly Progressive Apical Hypertrophic Cardiomyopathy: Not Everything is What It SeemsAhmed K Mahmoud, Juan M Farina, Kamal Awad, et al.
American Heart Journal|September 6, 2024
The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profileSaid Alsidawi, Kaitlin M Roehl, Juan Maria Farina, et al.
JACC. Advances|May 27, 2026
Long-Term Impact of Frailty on Outcomes Following Alcohol Septal Ablation in Hypertrophic Obstructive CardiomyopathyHritvik Jain, Nandan Patel, Jyoti Jain, et al.
Diabetes, Obesity & Metabolism|January 6, 2026
Increasing cardiovascular mortality in young adults with diabetes mellitus as a contributing cause in the United StatesYong-Hao Yeo, Boon-Jian San, Ghee-Kheng Lim, et al.
Biomedicines|April 29, 2025
Temporal Patterns of Holter-Detected Arrhythmias in Hypertrophic Cardiomyopathy Patients Treated with MavacamtenAmro Badr, Kaitlin Roehl, Mustafa Suppah, et al.
Pageof 10